Description

1. Question: Sadie is a 90-year-old patient who requires a new What changes in drug distribution with aging would influence prescribing for Sadie?
2. Question: Principles of prescribing for older adults include:
3. Question: Glen is an 82-year-old patient who needs to be prescribed a new drug. What changes in elimination should be taken into consideration when prescribing for Glen?
4. Question: A medication review of an elderly person’s medications involves:
5. Question: Steps to avoid polypharmacy include:
6. Question: Robert is a 72-year-old patient who has hypertension and He is at risk for common medication practices seen in the elderly including:
7. Question: To improve positive outcomes when prescribing for the elderly the nurse practitioner should:
8. Question: When an elderly diabetic patient is constipated the best treatment options include:
9. Question: Delta is an 88-year-old patient who has mild low-back What guidelines should be followed when prescribing pain management for Delta?
10. Question: Robert is complaining of poor Medications that may contribute to sleep problems in the elderly include:
11. Question: The GFRs for a 91-year-old woman who weighs 93 pounds and is 5’1″ with a serum creatinine of 1.1, and for a 202-pound, 25-year-old male who is 5’9″ with the same serum creatinine according to the Cockcroft Gault formula are:
12. Question: In geriatric patients, the percentage of body fat is What are the pharmacologic implications of this physiologic change?
13. Question: All of the following statements about the Beer’s List are true except:
14. Question: You are reviewing the data from several meta-analyses that addressed the most common causes of adverse drug reactions in the older adult. Which of the following would you find to be decreased and the most common cause of these problems in older adults?
15. Question: Which of the following is not consistent with the rules for geriatric prescribing:
16. Question: The Pediatric Research Equity Acts requires:
17. Question: The Best Pharmaceuticals for Children Act:
18. Question: The developmental variation in Phase I enzymes has what impact on pediatric prescribing?
19. Question: Developmental variation in renal function has what impact on prescribing for infants and children?
20. Question: Topical corticosteroids are prescribed cautiously in young children because:
21. Question: Liza is breastfeeding her 2-month-old son and has an infection that requires an What drug factors influence the effect of the drug on the infant?
22. Question: Drugs that are absolutely contraindicated in lactating women include:
23. Question: Zia is a 4-month-old patient with otitis Education of his parents regarding administering oral antibiotics to an infant includes:
24. Question: To increase adherence in pediatric patients a prescription medication should:
25. Question: Janie is a 5-month-old breastfed infant with a Treatment for her fever may include:
26. Question: The factor that has the greatest effect on males developing male sexual characteristics is:
27. Question: When assessing a male for hypogonadism prior to prescribing testosterone replacement, serum testosterone levels are drawn:
28. Question: Some research supports that testosterone replacement therapy may be indicated in which of the following diagnoses in men?
29. Question: The goal of testosterone replacement therapy is:
30. Question: While on testosterone replacement, hemoglobin and hematocrit levels should be Levels suggestive of excessive erythrocytosis or abuse are:
31. Question: Monitoring of an older male patient on testosterone replacement includes:
32. Question: When prescribing phosphodiesterase type 5 (PDE-5) inhibitors such as sildenafil (Viagra) patients should be screened for use of:
33. Question: Men who are prescribed phosphodiesterase type 5 (PDE-5) inhibitors for erectile dysfunction should be educated regarding the adverse effects of the drug which include:
34. Question: Male patients who should not be prescribed phosphodiesterase type 5 (PDE-5) inhibitors include:
35. Question: Monitoring of male patients who are using phosphodiesterase type 5 (PDE-5) inhibitors includes:
36. Question: Pernicious anemia is treated with:
37. Question: Premature infants require iron supplementation with:
38. Question: Breastfed infants should receive iron supplementation of:
39. Question: Valerie presents to the clinic with Her hemoglobin is 10.2 and her ferritin is 15 ng/mL. Initial treatment for her anemia would be:
40. Question: Chee is a 15-month-old male whose screening hemoglobin is 4 g/dL. Treatment for his anemia would be:
41. Question: Monitoring for a patient taking iron to treat iron deficiency anemia is:
42. Question: Valerie has been prescribed iron to treat her Education of patients prescribed iron would include:
43. Question: Allie has just had her pregnancy confirmed and is asking about how to ensure a healthy What is the folic acid requirement during pregnancy?
44. Question: Kyle has Crohn’s disease and has a documented folate Drug therapy for folate deficiency anemia is:
45. Question: Patients who are being treated for folate deficiency require monitoring of:
46. Question: The treatment of vitamin B12 deficiency is:
47. Question: The dosage of Vitamin B12 to initially treat pernicious anemia is:
48. Question: Before beginning IM vitamin B12 therapy, which laboratory values should be obtained?
49. Question: _______ should be monitored when vitamin B12 therapy is
50. Question: Anemia due to chronic renal failure is treated with:
51. Question: Kenneth is taking warfarin and is asking about what he can take for minor aches and The best recommendation is:
52. Question: Juanita had a deep vein thrombosis (DVT) and was on heparin in the hospital and was discharged on warfarin. She asks her primary care provider NP why she was getting both medications while in the hospital. The best response is to:
53. Question: The safest drug to use to treat pregnant women who require anticoagulant therapy is:
54. Question: The average starting dose of warfarin is 5 mg Higher doses of 7.5 mg daily should be considered in which patients?
55. Question: Cecil and his wife are traveling to Southeast Asia on vacation and he has come into the clinic to review his medications. He is healthy with only mild hypertension that is well He asks about getting “a shot” to prevent blood clots like his friend Ralph did before international travel. The correct respond would be:
56. Question: Robert, age 51 years, has been told by his primary care provider (PCP) to take an aspirin a Why would this be recommended?
57. Question: Sally has been prescribed aspirin 320 mg per day for her atrial She also takes aspirin four or more times a day for arthritis pain. What are the symptoms of aspirin toxicity for which she would need to be evaluated?
58. Question: Patient education when prescribing clopidogrel includes:
59. Question: For patients taking warfarin, INRs are best drawn:
60. Question: Patients receiving heparin therapy require monitoring of:
61. Question: The routine monitoring recommended for low molecular weight heparin is:
62. Question: When writing a prescription for warfarin it is common to write on the
63. Question: Education of patients who are taking warfarin includes discussing their Instructions include:
64. Question: Patients who are being treated with epoetin alfa need to be monitored for the development of:
65. Question: The FDA issued a safety announcement regarding the use of erythropoiesis-stimulating agents (ESAs) in 2010 with the recommendation that:
66. Question: When patients are started on darbepoetin alfa (Aranesp) they need monitoring of their blood counts to determine a dosage adjustment in:
67. Question: Jim is having a hip replacement surgery and would like to self-donate blood for the In addition to being prescribed epogen alpha he should also be prescribed:
68. Question: Monitoring for a patient being prescribed iron for iron deficiency anemia includes:
69. Question: Patient education regarding taking iron replacements includes:
70. Question: Patients with pernicious anemia require treatment with:
71. Question: The first laboratory value indication that vitamin B12 therapy is adequately treating pernicious anemia is:
72. Question: Patients who are beginning therapy with vitamin B12 need to be monitored for: